Quantcast

Latest stomach cancer Stories

2011-01-13 08:37:58

(Ivanhoe Newswire) -- The cost of fighting cancer will be a big one as our population continues to grow and age. If predictions by the National Institutes of Health are correct, the disease, which constantly requires advancement in diagnostic, treatment and follow-up tools, may rack up a price tag of $158 million (before inflation) or more by 2020. Researchers at the National Cancer Institute have reason to believe that the figure could look something more like $200 billion. These staggering...

2011-01-13 00:00:43

For the 5th year in a row, WorldMed Assist has observed an interesting phenomenon occurring around this time of year: an annual surge in weight loss surgeries. Concord, CA (PRWEB) January 12, 2011 For the 5th year in a row, WorldMed Assist has observed an interesting phenomenon occurring around this time of year: an annual surge in weight loss surgeries. Every year the number of people contacting the company for weight loss surgery dramatically increases after Thanksgiving. For the...

2011-01-04 15:28:10

A tiny light source and sensors at the end of an endoscope may provide a more accurate way to identify pre-cancerous cells in the lining of the esophagus. Developed by biomedical engineers at Duke University and successfully tested on patients during a clinical trial at the University of North Carolina at Chapel Hill, the device holds the promise of being a less invasive method for testing patients suspected of having Barrett's esophagus, a change in the lining of the esophagus due to acid...

2010-12-17 06:41:00

TOKYO, Dec. 17, 2010 /PRNewswire/ -- Taiho Pharmaceutical Co., Ltd., and its parent company, Otsuka Holdings Co., Ltd., announced today that the Committee for Medicinal Products for Human Use (CHMP), a division of the European Medicines Agency (EMA), has issued an opinion recommending approval of Teysuno(TM) (S-1), a novel oral anti-cancer agent, intended for the treatment of advanced gastric cancer in adults when given in combination with cisplatin. The Committee will now recommend that...

2010-12-09 18:32:21

Those who sufer with very-common GERD have low incidence of rare but deadly cancer, according to U-M researchers The risk of esophageal cancer among patients who suffer from gastroesophageal reflux disease (GERD) is not as high as many may think, according to new research from  University of Michigan gastroenterologists. GERD is considered a relative risk for developing esophageal adenocarcinoma, but the absolute risk is not known, says Joel Rubenstein, M.D., M.Sc., an investigator with...

2010-12-09 10:36:00

Those who suffer with very-common GERD have low incidence of rare but deadly cancer, according to U-M researchers ANN ARBOR, Mich., Dec. 9, 2010 /PRNewswire-USNewswire/ -- The risk of esophageal cancer among patients who suffer from gastroesophageal reflux disease (GERD) is not as high as many may think, according to new research from University of Michigan gastroenterologists. GERD is considered a relative risk for developing esophageal adenocarcinoma, but the absolute risk is not...

fcb4b4cc3cad4a15516e06b834f48c421
2010-11-06 09:30:00

A new study suggests that people who consume large quantities of red meat may have a greater chance of developing certain cancers of the throat and stomach than people who limit their intake of steaks and hamburgers. Reuters health reported Friday that researchers found only a small number of the 500,000 older U.S. adults studied developed cancers of the esophagus or stomach.  However, the risks were relatively greater among those who ate a lot of red meat. Study participants in the...

2010-10-22 18:53:05

People treated for cancer when they were children have a higher-than-average risk of gastrointestinal problems "“ some mild, some quite severe "“ in the years following treatment, according to a study to be presented at the 42nd Congress of the International Society of Paediatric Oncology (SIOP) in Boston on Sunday, Oct. 24. Investigators at Dana-Farber/Children's Hospital Cancer Center and their colleagues say their findings suggest that childhood cancer survivors and their...

2010-10-11 06:30:00

INDIANAPOLIS, Oct. 11 /PRNewswire-FirstCall/ -- Eli Lilly and Company (NYSE: LLY) announced today that its global Phase III trial evaluating ALIMTA® (pemetrexed for injection) in combination with cisplatin in patients with recurrent or metastatic squamous cell cancer of the head and neck (SCCHN) did not meet its primary endpoint for overall survival. Data were presented for the first time today at the 35th Annual Meeting of the European Society for Medical Oncology (ESMO)....

2010-10-05 06:42:00

GIESSEN, Germany, October 5, 2010 /PRNewswire/ -- - Biomarker 'M2-PK' Identified as Key Enzyme in Cancer Diagnosis and Therapy - Warburg hypothesis (named after the Nobel prize winner) confirmed - Cancer cells can be recognised by their metabolism - Scientists from Harvard Medical School in Boston report on the enzyme 'M2-PK' in a study in the renowned specialist journal 'Science' - Tests for detecting M2-PK in blood or also in stool samples are already available...


Word of the Day
Cthulhu
  • A gigantic fictional humanoid alien god being described with a head resembling an octopus and dragon wings and claws, around whom an insane cult developed.
  • Pertaining to the mythos of Cthulhu and additional otherworldly beings created by H. P. Lovecraft or inspired by his writings and imitators.
This word was invented in 1926 by H.P. Lovecraft for his short story, 'The Call of Cthulhu.' 'Cthulhu' may be based on the word 'chthonic,' which in Greek mythology refers to the underworld.
Related